Delivery Order SPE2DB20D3103-SPE2DB25FN5U2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,335.06 on August 6, 2025, for the supply of Sunosi 150 mg tablets (30-count). This is a firm fixed-price, non-set-aside contract with performance through August 7, 2025, to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $2,322.37 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price contract, placed through a non-set-aside competitive procurement, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.72 to AmerisourceBergen Drug Corp for SUNOSI 75 mg tablets (30-count) on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance to be completed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $1,345.47 to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Sunosi 150 mg tablets (30-unit quantity). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of April 25, 2025. The award was made to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, which serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SUNOSI 75 mg tablets (30-count) with a ceiling value of $1,792.60. This firm fixed-price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made on a...
- The Defense Logistics Agency awarded a delivery order valued at $2,169.35 to AmerisourceBergen Drug Corp for 30 tablets of Sunosi 75 mg on November 3, 2025, with an ultimate completion date of November 4, 2025. This delivery order represents a firm fixed price contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility. The award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,445.76 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count). This firm fixed-price contract represents a non-set-aside competitive award and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 24, 2025, with an ultimate completion date of September 25, 2025, for the supply of SUNOSI 75 mg tablets (30-count units). This firm fixed-price delivery order, valued at $1,792.60, represents a non-set-aside competitive award under an existing indefinite delivery contract vehicle. The contract was executed without set-aside restrictions,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,501.40 by the Defense Logistics Agency on September 18, 2025, for the supply of Sunosi 150 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract with a completion date of September 19, 2025. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 30 tablets of Sunosi 150 mg, a medication used to treat excessive daytime sleepiness. This competitive, firm fixed-price delivery order was awarded on September 15, 2025, with a ceiling value of $1,345.47 and an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and represents a small-value transaction under the company's larger federal pharmaceutical...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN5U2Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,345.47 for SUNOSI 150 mg tablets (30-count units) on April 24, 2025, with a completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical will be supplied from the contractor's Conshohocken, Pennsylvania facility, which serves as the company's corporate office and primary distribution hub for federal medical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for military and veteran healthcare systems through its comprehensive federal contract portfolio. The SPE2DX prime IDC vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, and specialty healthcare commodities—to support military healthcare programs globally. This delivery order for SUNOSI, a medication used to treat excessive daytime sleepiness, exemplifies the company's role in fulfilling specialized pharmaceutical needs across the Defense Health Agency and other federal healthcare systems through flexible, competitively awarded contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/24/25 |